GRAL

GRAIL
GRAL

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.14B
EV
$448.97M
Shares Outstanding
33.90M
Beta
-

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$26.00
P/E 2025E
-
P/Revenue 2025E
7.51x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About GRAIL, Inc.

gainify
GRAL

GRAIL, Inc.

GRAL

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic r...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Ragusa, Robert

Employees

1,000

Website

grail.com

IPO Date

2024-06-12

Headquarters

1525 O’Brien Drive, Menlo Park, California, 94025, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved